meriana ea phekolo ea kankere ea matšoafo

Meriana ea Kalafo ea Kankere ea Matšoafo: Tataiso e Feletseng Kankere ea matšoafo ke lefu le tebileng, le ho utloisisa tse teng meriana ea phekolo ea kankere ea matšoafo ke ea bohlokoa ho bakuli le malapa a bona. Tataiso ena e fana ka kakaretso ea likhetho tse fapaneng tsa kalafo, e shebane le meriana e sebelisoang le mekhoa ea eona ea ts'ebetso. Re tla hlahloba mefuta e fapaneng ea liphekolo le ho totobatsa bohlokoa ba merero ea motho ka mong ea kalafo e etselitsoeng litlhoko tsa mokuli ka mong. Lintlha tsena ke tsa merero ea thuto feela 'me ha lia lokela ho nkela keletso ea litsebi tsa bongaka sebaka. Kamehla buisana le ngaka ea hau ea oncologist kapa mofani oa tlhokomelo ea bophelo bakeng sa tlhahlobo le moralo oa kalafo.

Mefuta ea Meriana ea Phekolo ea Kankere ea Matšoafo

Targeted Therapy

Litlhare tse reriloeng li shebana le limolek'hule tse itseng ka har'a lisele tsa mofetše tse tsamaisang kholo ea tsona le ho phela. Meriana ena e sebetsa ka tsela e fapaneng le chemotherapy ea setso, ka sepheo sa ho fokotsa kotsi ho lisele tse phetseng hantle. Mehlala ea mekhoa ea phekolo e reretsoeng e kenyelletsa: EGFR inhibitors: Meriana ena e lebisa tlhokomelo ho epidermal growth factor receptor (EGFR), protheine e phethang karolo ea ho hōla ha lisele. Li sebetsa ka ho khetheha ho bakuli ba nang le liphetoho tsa EGFR. Mehlala e tloaelehileng e kenyelletsa gefitinib, erlotinib, le afatinib. Katleho le litla-morao li fapana ho ea ka mokuli ho ea ho mokuli. ALK inhibitors: Anaplastic lymphoma kinase (ALK) ke protheine e 'ngoe e ka tlatsetsang khōlong ea kankere ea matšoafo. ALK inhibitors, tse kang crizotinib, alectinib, le ceritinib, li lebisa protheine ena. Litlhare tse ling tse lebisitsoeng: Litlhare tse ling tse ngata tse lebisitsoeng lia fumaneha, tse shebaneng le limolek'hule tse fapaneng le litsela tse amanang le nts'etsopele ea mofetše oa matšoafo. Ngaka ea hau ea oncologist e tla fumana kalafo e nepahetseng ka ho fetesisa e ipapisitseng le litšobotsi tsa hau tse ikhethang tsa hlahala.

Chemotherapy

Chemotherapy e sebelisa lithethefatsi ho bolaea lisele tsa mofetše. Hangata meriana ena e sebelisoa hammoho le liphekolo tse ling ’me e ka ’na ea fanoa ka methapo kapa ka molomo. Lithethefatsi tse tloaelehileng tsa chemotherapy tse sebelisoang ho meriana ea phekolo ea kankere ea matšoafo li kenyelletsa cisplatin, carboplatin, paclitaxel, le docetaxel. Lithethefatsi tse khethehileng le motsoako oa tsona li itšetlehile ka sethala le mofuta oa kankere ea matšoafo. Litla-morao li ka ba tsa bohlokoa, 'me taolo e sebetsang e bohlokoa.

Immunotherapy

Immunotherapy e sebelisa sesole sa 'mele ho loantša mofetše. Meriana ena e sebetsa ka ho matlafatsa sesole sa 'mele ho lemoha le ho senya lisele tsa mofetše. Checkpoint inhibitors, joalo ka pembrolizumab le nivolumab, ke mehlala ea lithethefatsi tsa immunotherapy tse sebelisoang meriana ea phekolo ea kankere ea matšoafo. Lithethefatsi tsena li lebisa liprotheine tse thibelang sesole sa 'mele ho hlasela lisele tsa mofetše. Li ka fana ka melemo e mengata empa hape li tla le litla-morao tse ka bang teng.

Liphekolo Tse Ling

Ntle le litlhare, liphekolo tse ling hangata li kenyelletsoa ka botlalo meriana ea phekolo ea kankere ea matšoafo rera. Tsena li ka kenyelletsa: Kalafo ea radiation: E sebelisa mahlaseli a matla a phahameng ho bolaea lisele tsa mofetše. Opereishene: Ho tlosoa ha hlahala ea mofetše. Tlhokomelo ea tšehetso: E tsepamisitse maikutlo ho laola litla-morao le ho ntlafatsa boleng ba bophelo ba mokuli.

Ho Khetha Phekolo e Nepahetseng

Khetho ea meriana ea phekolo ea kankere ea matšoafo e itšetlehile haholo ka motho ka mong 'me e itšetlehile ka lintlha tse' maloa, ho akarelletsa le: Mofuta le mohato oa kankere ea matšoafo: Mefuta e sa tšoaneng ea kankere ea matšoafo e arabela ka tsela e fapaneng liphekolong tse sa tšoaneng. Boemo ba mofetše le bona bo ama liqeto tsa kalafo. Bophelo bo botle ba mokuli ka kakaretso: Bophelo bo botle ba mokuli le maemo afe kapa afe a neng a le teng pele a ka ama mamello ea bona ea liphekolo tse itseng. Teko ea liphatsa tsa lefutso: Ho etsa liteko tsa liphetoho tse itseng liseleng tsa mofetše ho ka thusa ho tataisa khetho ea kalafo.

Liphello le Tsamaiso

Tse ngata meriana ea phekolo ea kankere ea matšoafo e ka baka litla-morao. Tsena li ka tloha ho tse bonolo ho ea ho tse matla 'me li fapana ho itšetlehile ka meriana e khethehileng le mokuli ka bomong. Ho bohlokoa ho buisana ka litla-morao tse ka bang teng le mofani oa tlhokomelo ea bophelo le ho theha maano a taolo ea bona. Puisano e bulehileng le sehlopha sa hau sa bongaka e bohlokoa nakong eohle ea kalafo.

Moo U ka Fumanang Boitsebiso bo Eketsehileng

Bakeng sa tlhaiso-leseling e batsi ka mofetše oa matšoafo le kalafo ea ona, o ka sheba mehloli e tsebahalang joalo ka National Cancer Institute (NCI) https://www.cancer.gov/ le American Lung Association (ALA) https://www.lung.org/. Hopola, ho batla boeletsi ba bongaka ba litsebi ke ntho ea bohlokoa ho sebetsana le mathata a kalafo ea mofetše oa matšoafo. Bakeng sa tlhokomelo e tsoetseng pele le ea motho ka mong, nahana ka ho buisana le litsebi litsing tse tummeng tse kang Shandong Baofa Cancer Research Institute. https://www.baofahospital.com/.

Mofuta oa Meriana	Mehlala	Mokhoa oa Ts'ebetso	Liphello tse ka 'nang tsa etsahala
Li-inhibitors tsa EGFR	Gefitinib, Erlotinib	E thibela pontšo ea EGFR	Lekhopho, letšollo, mokhathala
ALK Inhibitors	Crizotinib, Alectinib	E thibela pontšo ea ALK	Ho nyekeloa ke pelo, ho hlatsa, ho pipitleha
Chemotherapy	Cisplatin, Carboplatin	E senya DNA	Ho nyekeloa ke pelo, ho hlatsa, ho lahleheloa ke moriri
Immunotherapy	Pembrolizumab, Nivolumab	E ntlafatsa karabelo ea 'mele ea ho itšireletsa mafung	Mokhathala, lekhopho, letšollo

Boitsebiso bona bo reretsoe merero ea thuto feela 'me ha boa lokela ho nkoa e le keletso ea bongaka. Kamehla buisana le setsebi se tšoanelehang sa tlhokomelo ea bophelo bakeng sa tlhahlobo le moralo oa kalafo.